Hints and tips:
Related Special Reports
...Gilead has worked with scientists at Accelerated Clinical Trials Ltd to develop a blood cancer treatment....
...Isomorphic Labs has partnerships with pharmaceutical companies Eli Lilly and Novartis....
...Hassabis stated the goal days after announcing Isomorphic Lab’s first two pharmaceutical partnerships with Eli Lilly and Novartis, which came to a combined value of up to $3bn, in deals set to transform...
...Browns is owned by Sri Lankan holding company LOLC Holdings, whose portfolio spans cars, pharmaceuticals, mining, agriculture and financial services....
...FDA inspections of international plants dropped sharply during the Covid-19 pandemic....
...This is aided by the fact that groups such as Novartis are based in the city, soon to be joined by AstraZeneca....
...Several international funds took part in the Series A round, which was led by Novartis Venture Fund and includes follow-on investment by the Dementia Discovery Fund....
...That prompted Shionogi in late October to upgrade its annual guidance for domestic sales of Xocova, while it lowered its target for international sales....
...Britain is also falling down global rankings in running clinical trials; Novartis recently scrapped a major trial of a cholesterol drug....
...The latest £200mn project was a collaboration funded by the government, Wellcome Trust, Britain’s biggest biomedical charity, and four pharmaceutical companies....
...Big share moves on the European stock exchanges include Novartis, Orange and Royal Mail owner International Distributions Services: Shares in Novartis climbed 6 per cent to the top of the benchmark Stoxx...
...In 2020, when pharmaceutical manufacturers Roche and Novartis were fined €444mn for allegedly pushing their jointly marketed eye medicine Lucentis over a cheaper alternative, Thill-Tayara successfully argued...
...PMI chief executive Jacek Olczak told the Financial Times that Vectura’s sales had suffered because of the reluctance of pharmaceutical partners to work with the company....
...The company is also expanding beyond its headquarters in London to a second office in Lausanne, Switzerland, home to a host of leading pharma companies including Roche, Novartis and Bayer, and Isomorphic...
...Also attracting investors is Shanghai-based Fu Shou Yuan International, China’s biggest funeral services provider and seller of burial plots....
...That’d be bad news for Hikma Pharmaceuticals (27.2 per cent). What about board chairs and their deputies?...
...Risk management Winner: Johnson & JohnsonOriginality: 8; Leadership: 9; Impact: 9; Total: 26The litigation team in Asia-Pacific designed a digital system for the pharmaceutical business to improve its management...
...and EQT’s £4.5bn takeover of veterinary drugmaker Dechra Pharmaceuticals....
...But Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers and Associations, said governments had gone from appreciating rapid innovation during the pandemic, to needing...
...for the US and international markets....
...Novartis said it did not think the decline in sales was linked to reports of deaths of two children who had taken the drug....
...Shares in Fosun International, the conglomerate’s main listed entity, fell as much as 1.5 per cent in Hong Kong on Thursday....
...Analysts say Takeda faces a challenge to deliver on its decade-old strategy to compete with more established international rivals in the global vaccine market....
...of a core Chinese pharmaceutical unit....
...Several private equity firms are considering bids of up to $25bn for Sandoz, the generic drugs business belonging to pharmaceutical company Novartis, according to multiple people with knowledge of the situation...
International Edition